BioArctic AB (publ) (BRCTF)
OTCMKTS
· Delayed Price · Currency is USD
20.90
+2.16 (11.52%)
Jun 13, 2025, 2:15 PM EDT
BioArctic AB Employees
BioArctic AB had 107 employees as of December 31, 2024. The number of employees increased by 19 or 21.59% compared to the previous year.
Employees
107
Change (1Y)
19
Growth (1Y)
21.59%
Revenue / Employee
$1,303,112
Profits / Employee
$774,619
Market Cap
1.85B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Elite Pharmaceuticals | 64 |
Tian'an Technology Group | 8 |
CytoDyn | 9 |
Glass House Brands | 374 |
Northwest Biotherapeutics | 25 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
BioArctic AB News
- 11 days ago - BioArctic's Capital Markets Day 2025 - entering a new era of growth - PRNewsWire
- 4 weeks ago - Eisai projects Leqembi® revenue to total JPY 76.5 billion for fiscal year 2025 (April 2025 - March 2026) - PRNewsWire
- 4 weeks ago - Invitation to presentation of BioArctic's first quarter report for January - March 2025 on May 21 at 9.30 a.m. CET - PRNewsWire
- 5 weeks ago - Exidavnemab phase 2a study expanded to include MSA patients - PRNewsWire
- 2 months ago - The European Commission refers lecanemab decision to Appeal Committee - PRNewsWire
- 2 months ago - BioArctic's partner Eisai presents sales simulation for Leqembi® at its annual press conference - PRNewsWire
- 3 months ago - BioArctic receives Orphan Drug Designation for exidavnemab the US - PRNewsWire
- 3 months ago - Therapeutic Goods Administration decides not to register lecanemab in Australia - PRNewsWire